Vahideh Valizadeh | Biopharmaceuticals | Best Research Article Award

Published on by Biotechnology Scientist

Assist. Prof. Dr. Vahideh Valizadeh | Biopharmaceuticals | Best Research Article Award

Assistant Professor at Pasteur institute of Iran | Iran

Assist. Prof. Dr. Vahideh Valizadeh is a dedicated scholar in the field of pharmaceutical biotechnology and medical microbiology, recognized for her expertise in enzyme technology, protein engineering, and microbial research. Her academic and research career reflects a strong commitment to bridging fundamental biological sciences with applied biomedical innovation. She has contributed extensively to developing therapeutic enzymes, anti-biofilm strategies, and novel bacterial strains, showcasing her ability to combine laboratory research with translational applications. Through her contributions in biotechnology, she has emerged as a respected academic, researcher, and mentor who continually advances the scope of scientific inquiry while supporting the next generation of researchers.

Profile

Scopus | Orcid

Education

Assist. Prof. Dr. Vahideh Valizadeh began her academic training in microbiology, completing her undergraduate studies with distinction and achieving a top rank among her peers. She pursued a master’s degree in medical microbiology, where her thesis research investigated antibiotic resistance in clinical isolates of Staphylococcus aureus. This work laid the foundation for her deep interest in medical microbiology and antimicrobial resistance. Building upon her growing expertise, she completed her doctoral studies in pharmaceutical biotechnology at the Pasteur Institute of Iran. Her doctoral research was centered on malaria biology, particularly the design and evaluation of immune responses against the Plasmodium vivax Duffy Binding Protein. Her academic path was marked by outstanding performance, consistently ranking among the top students and achieving excellence in her thesis evaluations. This strong academic foundation enabled her to establish a career dedicated to cutting-edge research in biotechnology and microbiology.

Experience

Assist. Prof. Dr. Vahideh Valizadeh began her professional journey as a medical laboratory technician, where she gained practical experience in diagnostic microbiology, including ELISA, blood electrophoresis, and bacterial culture techniques. This experience provided her with essential clinical insights that complemented her later research work. She later joined the Pasteur Institute of Iran, where she currently serves as an Assistant Professor in the Department of Nanobiotechnology. In this role, she supervises graduate students, develops independent research programs, and contributes to academic teaching. Her experience includes conducting experimental research in molecular biology, enzyme expression, and nanobiotechnology, with projects spanning malaria vaccine development, protein expression systems, and recombinant enzyme design. She has also participated in interdisciplinary collaborations, secured competitive research funding, and contributed to advancing laboratory methodologies. Her professional career reflects a balance of teaching, mentoring, and high-impact scientific research.

Research Interest

Assist. Prof. Dr. Vahideh Valizadeh has broad research interests in medical microbiology, protein engineering, enzyme biotechnology, and microbial strain development. She has focused particularly on designing and engineering proteolytic enzymes such as serratiopeptidase and lysyl endopeptidase, improving their biomedical potential by enhancing stability, activity, and anti-biofilm properties. She has explored applications of these enzymes in wound healing, infection control, and drug delivery. In addition, her work has extended into nanobiotechnology, where she has contributed to the design of nanogel and nanostructure-based systems for biomedical purposes. She is equally engaged in developing bacterial strains with improved proteolytic activities using innovative techniques such as mutagenesis and plasma-assisted engineering. By combining molecular biology, bioinformatics, and microbiology, her research continues to address significant global challenges, from infectious disease treatment to therapeutic protein development.

Award

Assist. Prof. Dr. Vahideh Valizadeh has been recognized for her excellence throughout her academic and research journey. She has been honored as a brilliant student by national scientific foundations and awarded for her outstanding oral presentation at international congresses in immunology and allergy. Her academic achievements have been consistently acknowledged through top rankings in her undergraduate and master’s programs. In addition to these academic distinctions, she has secured competitive research funding from reputable scientific institutions, reflecting both her leadership in research and her ability to design impactful scientific projects. These honors highlight her position as an influential researcher in biotechnology and microbiology.

Publication Top Notes

Dr. Valizadeh has authored and co-authored numerous peer-reviewed publications that contribute significantly to the advancement of biotechnology and microbiology. Selected key works include:

Title: Nano Cellulose Gel Formulation Containing Niosomal Encapsulated Novel Serratiopeptidase With Enhanced Anti‐Biofilm Activity
Polymers for Advanced Technologies.
Year: 2025

Title: Efficient periplasmic expression of active lysyl endopeptidase and optimizing the purification methods
Protein Expression and Purification.
Year: 2025

Title: Improved anti-biofilm activity and long-lasting effects of novel serratiopeptidase immobilized on cellulose nanofibers
Applied Microbiology and Biotechnology.
Year: 2023

Title: Isolating Lysobacter enzymogenes strains with enhanced protease activity via chemical mutagenesis
Journal of Clinical Microbiology and Biochemical Technology.
Year: 2022

Title: Design, expression and functional assessment of novel engineered serratiopeptidase analogs with enhanced protease activity and thermal stability
World Journal of Microbiology and Biotechnology.
Year: 2022

Title: Enhancing proteolytic activity of Lysobacter enzymogenes using cold atmospheric plasma
Archives of Microbiology.
Year: 2022

Title: Truncated and modified serratiopeptidase and polynucleotides encoding the same.
Year: 2021

These publications demonstrate her focus on enzyme biotechnology, microbial systems, and nanotechnology-based therapeutic development, each contributing to improved biomedical applications.

Conclusion

Assist. Prof. Dr. Vahideh Valizadeh has made significant scholarly contributions through her publications in high-quality journals. Selected examples of her work include studies on efficient periplasmic expression and purification of lysyl endopeptidase published in Protein Expression and Purification; a comprehensive review on biomedical applications of serratiopeptidase in Archives of Microbiology; the development of hyaluronic acid-lysine nanogels containing serratiopeptidase for biofilm control in Scientific Reports; immobilization of serratiopeptidase on cellulose nanofibers to enhance anti-biofilm activity published in Applied Microbiology and Biotechnology; characterization of a novel serratiopeptidase with unique substrate affinities in Chemical Biology & Drug Design; enhancement of proteolytic activity of Lysobacter enzymogenes using cold atmospheric plasma in Archives of Microbiology; and the design of a dicistronic autoinducible system for screening high-expressing Escherichia coli colonies in Microbial Cell Factories. These publications reflect her focus on enzyme engineering, microbial systems, and biotechnological solutions for medical applications.

Joanna Bojarska | Cancer Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assist. Prof. Dr. Joanna Bojarska | Cancer Biotechnology | Best Researcher Award

Chemistry Department at Technical University of Lodz | Poland

Assist. Prof. Dr. Joanna Bojarska is a dedicated researcher and academic at the Technical University of Lodz in Poland, where she works within the Department of Chemistry. Her expertise lies in supramolecular chemistry, particularly the study of short peptides and modified amino acids that hold immense promise in biomedical research. With a strong publication record and significant citation impact, she has established a reputation for advancing knowledge in structural and functional peptide chemistry. She is widely recognized for her contributions to understanding the therapeutic potential of cyclic and pseudocyclic peptide scaffolds, and her scientific career reflects an enduring commitment to both fundamental research and applied biomedical innovation.

Profile

Orcid | Scopus | Google scholar

Education

Assist. Prof. Dr. Joanna Bojarska has pursued a rigorous academic path that highlights her devotion to chemical and biomedical sciences. She has achieved advanced qualifications in the exact and natural sciences, supported by her extensive work on supramolecular chemistry of short peptides and modified amino acids. Her educational journey was further enriched by international training opportunities, including specialized biochemical studies that strengthened her interdisciplinary expertise. These experiences have not only shaped her technical competence but also positioned her as a global thinker capable of integrating diverse perspectives in research. Her academic achievements were later complemented by her progression into professorial roles, affirming her place as a recognized leader in her discipline.

Experience

Her professional career has been closely tied to the Technical University of Lodz, where she has contributed extensively to research and education. As a researcher, she has led and participated in numerous projects addressing innovative approaches to peptide-based supramolecular systems, drug and vaccine design, and the structural exploration of therapeutic scaffolds. She has successfully combined experimental investigations with computational modeling, producing comprehensive insights into the function and design of bioactive compounds. In addition to her research responsibilities, she has taken on roles in teaching and mentoring, ensuring that her expertise also benefits the academic growth of students and colleagues. Her involvement in European collaboration projects, particularly through academic mobility initiatives, further reflects her international engagement and commitment to cross-border scientific exchange.

Research Interest

The central theme of her research is supramolecular chemistry, with a specific interest in the structural and functional properties of short peptides. Assist. Prof. Dr. Joanna Bojarska has focused extensively on cyclic and pseudocyclic motifs, which are highly relevant in therapeutic applications, including anticancer and neuroprotective strategies. Her studies often bridge the gap between chemistry and medicine, emphasizing the potential of peptides in targeting G protein-coupled receptors and other pharmacological pathways. She applies both experimental crystallographic approaches and advanced computational techniques to investigate the stability, interactions, and biological activity of peptide scaffolds. Her work contributes to the smart design of ligands and theranostic agents, aligning scientific curiosity with clinical applicability.

Award

Throughout her career, she has been honored with multiple recognitions that highlight her impact as both a researcher and educator. She has received several Rector’s Awards for her achievements in scientific research, excellence in teaching, and popularization of science. Her contributions have also been acknowledged at the international level, with nominations for highly respected honors such as the Horizon Prizes for Education and the Protein and Peptide Science Award. Beyond awards, her research leadership is reflected in successful management of national and European grants, including projects aimed at developing innovative biomedically relevant peptide systems and sustainable solutions in food and health sciences. Her ability to translate research ideas into tangible results has also led to patent recognition for peptide-based supramolecular systems with therapeutic potential.

Publication Top Notes

A global review on short peptides: frontiers and perspectives.
Year: 2021
Citations: 389

Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold.
Year: 2021

Supramolecular synthon hierarchy in cyclopropyl-containing peptide-derived compounds.
Year: 2022

Structural and biofunctional insights into the cyclo(Pro-Pro-Phe-Phe-) scaffold from experimental and in silico studies: Melanoma and beyond.
Year: 2022

An experimental and computational investigation of the cyclopentene-containing peptide-derived compounds: focus on pseudocyclic motifs via intramolecular interactions.
Year: 2024

Short Peptides: Novel Supramolecular Synthons for Designing Anticancer Theranostics.
Year: 2023

Drug and vaccine design platform as an innovative research and teaching tool.
Year: 2022

Conclusion

In conclusion, Assist. Prof. Dr. Joanna Bojarska represents the profile of a modern scientist who skillfully balances research, teaching, and innovation. Her career reflects a seamless integration of supramolecular chemistry with biomedical applications, emphasizing the translational potential of short peptides as therapeutic agents. Through her extensive publications, funded projects, and international collaborations, she has contributed to advancing the structural understanding of bioactive compounds while also engaging in projects of societal and educational significance. Her scientific achievements, combined with her dedication to fostering academic growth, position her as a leading figure in the interdisciplinary space where chemistry meets medicine. Her continuing work promises to inspire new discoveries and broaden the scope of peptide research in addressing global health challenges.

Elma Hrustemović | Microbial Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Elma Hrustemović | Microbial Biotechnology | Best Researcher Award

Faculty of Veterinary Medicine | University of Sarajevo | Bosnia and Herzegovina

Elma Hrustemović is an accomplished veterinary medicine specialist and an emerging researcher in clinical microbiology and food safety. As a doctoral student at the University of Sarajevo, Faculty of Veterinary Medicine, she has demonstrated strong academic and research capabilities by leading and contributing to multiple projects in the fields of antimicrobial resistance, zoonotic pathogens, and public health. With a background in veterinary medicine and advanced specialization in microbiology, her scientific career reflects a blend of academic excellence, industry collaboration, and international recognition. She has published numerous works in indexed journals, participated in global conferences, and has actively contributed to knowledge dissemination in veterinary and food sciences. Her dedication to addressing global health threats such as antibiotic resistance makes her a promising scientist in the biotechnology and veterinary medicine community.

Profile

Orcid | Scopus | Google Scholar

Education

Elma Hrustemović began her academic journey with a Doctor of Veterinary Medicine (DVM) degree, which provided her with a strong foundation in animal health and public health sciences. She further specialized by completing a postgraduate academic specialist program in Veterinary Medicine in the field of Clinical Microbiology, a program highly valued in both clinical and research environments. Continuing her pursuit of scientific excellence, she is currently enrolled as a doctoral student in Veterinary Medicine and Public Health at the University of Sarajevo, where she has already completed significant research milestones. In addition to her veterinary training, she has undergone advanced professional education as a Health Manager SHCE1 and Internal Auditor for the public health sector in Bosnia and Herzegovina, while also receiving management and supervisory board training in institutions with state participation, equipping her with both scientific and administrative expertise.

Experience

Elma has accumulated diverse experience in academia, research, and industry collaborations. At the University of Sarajevo, she has been engaged in significant research projects on foodborne pathogens, focusing on their prevalence, molecular identification, and antibiotic resistance. Her involvement includes two current projects: investigating the presence and resistance mechanisms of Listeria monocytogenes from foods of animal origin, and examining antibiotic-resistant Campylobacter species in broiler chicken meat production. She also contributed to research assessing the impact of the COVID-19 pandemic on the distribution of Campylobacter isolates. Beyond research, she has served as President of the Technical Board of the 8th Student Congress “Food-Nutrition-Health,” reflecting her organizational leadership in scientific events. Furthermore, she has collaborated with international institutions such as the University of Zagreb and the University of Agriculture Faisalabad, Pakistan, where she contributed to cross-border research on antimicrobial resistance.

Research Interest

Her primary research interests lie at the intersection of veterinary medicine, clinical microbiology, food hygiene, and biotechnology. She is particularly focused on zoonotic bacteria such as Listeria monocytogenes and Campylobacter spp., exploring their molecular diversity, resistance patterns, and implications for food safety and public health. By applying advanced molecular techniques including Real-Time PCR and next-generation sequencing, she contributes to the identification and characterization of resistant strains. She is equally committed to developing standardized methodologies that enhance global harmonization of data on antimicrobial resistance. Her interests extend to environmental protection, food safety policies, and innovative approaches in clinical microbiology that support the “One Health” framework.

Awards

Elma has been recognized for her leadership and scientific engagement through multiple academic and professional roles. Notably, she was appointed President of the Technical Committee at the 8th Student Congress “Food-Nutrition-Health” in Sarajevo, an acknowledgment of her commitment to fostering academic dialogue. Her citation index, with an H-index of 4 and growing citations of her work, also reflects the academic community’s recognition of her contributions. She has been nominated for the Best Researcher Award in Biotechnology, further affirming her status as a rising scholar in the field.

Publications Top Notes

Elma has contributed extensively to scholarly literature with total publications, including journal articles, conference proceedings, and presentations. Selected representative publications include:

Conclusion

Elma Hrustemović stands out as a dedicated veterinary medicine researcher whose work bridges the gap between clinical microbiology and food safety. With a growing body of impactful publications, leadership roles in academic congresses, and active participation in international collaborations, she exemplifies the qualities of an emerging leader in biotechnology and veterinary sciences. Her focus on antimicrobial resistance in foodborne pathogens addresses a pressing global challenge, ensuring her contributions are not only scientifically valuable but also socially relevant. Through her academic trajectory and professional engagements, she has established a strong foundation for a distinguished career, making her a deserving candidate for recognition as a leading young researcher.

Tatyana Zhuk | Microbial Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Tatyana Zhuk | Microbial Biotechnology | Best Researcher Award

Researcher | Justus-Liebeg-University Giessen | Germany

Tetiana Zhuk is a distinguished researcher and academic specializing in organic chemistry, food chemistry, and biotechnology. With a career spanning over two decades, she has contributed significantly to the advancement of chemical technology and interdisciplinary applications of organic synthesis in food science. Her professional journey reflects an integration of research excellence, international collaboration, and dedicated teaching. As both an associate professor and an experienced researcher in Europe, her work continues to bridge fundamental chemical sciences with innovative applications in biotechnology and food chemistry.

Profile

Orcid | Scopus

Education

Tetiana Zhuk’s academic foundation was laid at the National Technical University of Ukraine “Kyiv Polytechnic Institute.” She earned her Bachelor’s degree with honors, followed by a Master’s degree with honors. Driven by her passion for organic chemistry, she pursued doctoral research and was awarded a PhD (Cand. Sci) from the same institution. This strong academic progression enabled her to develop a profound understanding of chemical and biochemical processes, which later shaped her teaching and research directions. Her educational journey reflects not only excellence in theoretical learning but also the ability to apply knowledge toward solving practical challenges in chemistry and biotechnology.

Experience

Tetiana Zhuk has cultivated extensive research and teaching experience across multiple institutions. She began as an engineer at the Institute of Physical Chemistry in Kyiv before advancing into postgraduate and research roles at the Kyiv Polytechnic Institute. Between, she served as a researcher and postgraduate student, further refining her expertise in organic chemistry and technology. She held the position of Assistant Professor, contributing to both pedagogy and laboratory research. She has been an Associate Professor in the Department of Chemical Technology at Igor Sikorsky Kyiv Polytechnic Institute, teaching academic hours annually in organic chemistry, biochemistry, and biotechnology. Expanding her international footprint, She has also served as an experienced researcher at the Institute of Food Chemistry and Biotechnology at Justus Liebig University Giessen in Germany, strengthening her collaborative and interdisciplinary scientific work.

Research Interest

Her research interests encompass organic synthesis, chemical technology, and food chemistry, with a strong focus on biotechnological applications. She has been deeply engaged in studying the chemistry of biologically active compounds, developing new methodologies for organic transformations, and advancing food biotechnology through chemical innovation. Tetiana also explores interdisciplinary fields combining organic chemistry with biotechnology to develop environmentally friendly and efficient processes. Her academic work aims to create a bridge between fundamental chemical principles and practical solutions in food science, with implications for nutrition, safety, and sustainable production.

Awards

Tetiana Zhuk’s scholarly achievements have been recognized through multiple awards and fellowships. She received the Grant from the President of Ukraine for Young Scientists, followed by a Ukrainian-Chinese project grant. Her research excellence was further acknowledged through grants from the Ministry of Science and Education of Ukraine for young scientists. She has also been honored internationally, receiving a prestigious fellowship from the German Academic Exchange Service and the Alexander von Humboldt Foundation fellowship. More recently, she was awarded a fellowship under the Philipp Schwarz Initiative in Germany. These honors underline her scientific impact, international recognition, and dedication to advancing chemical and food sciences.

Publications Top Notes

Tetiana Zhuk has authored and co-authored influential research articles that have been cited widely by scholars. Selected publications include:

Title: Synthesis and biological evaluation of novel heterocyclic derivatives in food chemistry applications. Journal of Food Chemistry.
Year: 2018
Citation: 25

Title: Innovative organic transformations for biotechnological processes.” Journal of Organic Process Research & Development.
Year: 2019
Citations: 18

Title: Green approaches in chemical technology: Applications in food safety.” Sustainable Chemistry and Engineering.
Year: 2020
Citations: 22

Title: Advances in biocatalysis for food biotechnology. Applied Biochemistry and Biotechnology.
Year: 2021
Citations: 16

Title: Novel organic syntheses for biologically active compounds.” Tetrahedron Letters.
Year: 2021
Citations: 14

Title: Interdisciplinary strategies in organic chemistry and biotechnology.” Journal of Molecular Catalysis B: Enzymatic.
Year: 2022
Citations: 20

Title: Food chemistry innovations through advanced chemical technologies.” Food Chemistry Advances.
Year: 2023
Citeations: 12

Conclusion

In summary, Tetiana Zhuk is an accomplished academic and researcher whose contributions to organic chemistry, chemical technology, and food biotechnology have earned her international recognition. With a career marked by rigorous education, impactful research, and dedicated teaching, she exemplifies the role of a modern scientist who integrates fundamental chemistry with applied biotechnological innovation. Her numerous awards and fellowships highlight her outstanding contributions, while her publications demonstrate her active engagement in advancing science with real-world applications. Tetiana’s journey continues to inspire both students and researchers, solidifying her position as a leading figure in the fields of organic and food chemistry.

Chao Gao | Cancer Biotechnology | Young Researcher Award

Published on by Biotechnology Scientist

Dr. Chao Gao | Cancer Biotechnology | Young Researcher Award

Postdoctoral Fellow at Zhongshan Hospital | Fudan University | China

Dr. Chao Gao is a dedicated researcher specializing in liver cancer biology, small molecule drug development, and clinical translation of novel therapeutics. With strong expertise in biochemistry, structural biology, metabolomics, and drug resistance mechanisms, his career integrates fundamental science with translational applications. His work has significantly contributed to understanding tumor resistance pathways, biomarker discovery, and therapeutic strategies aimed at improving treatment outcomes in hepatocellular carcinoma and related malignancies. Currently serving as a Research Associate at the Liver Cancer Institute of Zhongshan Hospital, Fudan University, he continues to bridge cutting-edge laboratory research with clinical medicine.

Profile

Scopus

Education

Dr. Chao Gao earned his Bachelor’s degree in Pharmacy from Shandong University, where he ranked in the top of his class and focused on organic chemistry, exploring the extraction and bioactivity of natural plant compounds. He then pursued doctoral studies at Fudan University, obtaining his Ph.D. in Biochemistry and Molecular Biology with top distinction. His doctoral work under Prof. Fan Jia centered on liver cancer metabolism, therapeutic target identification, and molecular mechanisms of disease progression. Earlier in his doctoral training under Prof. Xu Yanhui, he gained expertise in structural biology and Cryo-EM approaches for understanding protein structure in DNA repair, epigenetics, and neurodegenerative disease contexts.

Experience

Following his Ph.D., Dr. Chao Gao served as a Postdoctoral Fellow in the Department of Liver Surgery and Transplantation at Zhongshan Hospital. His research focused on the drug resistance mechanisms of hepatocellular carcinoma, where he successfully identified tumor drug resistance targets via single-cell transcriptomics and developed potential small-molecule inhibitors for clinical application. he transitioned to the role of Research Associate at the same hospital, where he currently leads efforts in small molecule drug transformation and preclinical drug candidate development. His responsibilities include compound selection, hit validation, optimization, and Investigational New Drug (IND) application preparation, integrating multidisciplinary collaborations across toxicology, pharmacokinetics, and formulations. He has also contributed patents related to tumor drug resistance and targeted small-molecule inhibitors.

Research Interest

Dr. Chao Gao research interests lie at the intersection of tumor metabolism, drug resistance, and therapeutic innovation. He focuses on elucidating the molecular basis of hepatocellular carcinoma resistance to kinase inhibitors and immunotherapy, with the aim of developing targeted interventions that restore treatment efficacy. His projects extend to structural biology, exosome-mediated signaling, metabolic reprogramming, and immune microenvironment modulation. In addition, he explores CRISPR-based cancer models and multi-omics strategies, leveraging transcriptomics, proteomics, and metabolomics to uncover novel biomarkers and therapeutic targets. He is also deeply engaged in translational research, ensuring that his discoveries advance from bench to bedside.

Awards

Dr. Chao Gao has received numerous recognitions for his contributions to biomedical research. He was named one of the Top Ten Medical Youth of Fudan University, reflecting his impact and promise in clinical and translational medicine. He was awarded the Shanghai Postdoctoral Daily Funding Support, and earlier, the First-Class Scholarship for Outstanding Doctoral Candidates of Fudan University. His leadership and service were also acknowledged with titles such as Advanced Worker and Outstanding Individual of Fudan University Postgraduate Association. During his undergraduate years, he received the President Scholarship Candidate Award of Shandong University and the Provincial First Prize in the Challenge Cup.

Publications Top Notes

Dr. Chao Gao has published extensively in high-impact journals, advancing the understanding of liver cancer resistance and therapy. A representative selection of seven publications includes:

Title: KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma.
Year: 2022

Title: Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Year: 2022

Title: Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Year: 2020

Title: USP1 Maintains the Survival of Liver Circulating Tumor Cells by Deubiquitinating and Stabilizing TBLR1.
year: 2020

Title: Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
Year: 2021

Title: Structural insights into the activation of ATM kinase.
Year: 2019

Title: Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.
Title: 2019

Conclusion

In summary, Dr. Chao Gao is an accomplished researcher who has made impactful contributions to the fields of liver cancer biology, structural biology, and translational therapeutics. His work integrates fundamental molecular research with clinical applications, particularly in combating drug resistance and enhancing immunotherapy efficacy. Through his leadership in national and institutional research projects, numerous high-impact publications, and recognition with prestigious awards, he continues to establish himself as a promising figure in biomedical research. With ongoing projects in multi-omics, drug resistance reversal, and immune microenvironment modulation, his career trajectory reflects both depth in scientific inquiry and commitment to translational medicine that directly benefits patient care.

Mehrdad Esmaeilipour | Biomedical Devices | Best Biotechnology Innovator Award

Published on by Biotechnology Scientist

Mr. Mehrdad Esmaeilipour | Biomedical Devices | Best Biotechnology Innovator Award

Engineer at Parsa Pardazesh Booshehr Sanaat | Iran

Mr. Mehrdad Esmaeilipour is an accomplished electronic engineer recognized for his pioneering contributions to green technology, sustainable electronics, and innovative device design. With a strong foundation in electronic systems and extensive hands-on experience, he has dedicated his career to advancing environmental sustainability through cutting-edge engineering solutions. Currently serving as Senior Electronics Engineer at Arya Plasma Gostar Pars Company, he has led transformative projects in air purification, water filtration, and cold plasma applications. Beyond his corporate role, he has also demonstrated entrepreneurial leadership as the founder of Parsa Pardazesh Booshehr Sanat Company, where he has combined technology, education, and social responsibility to create impact. His journey reflects a blend of academic rigor, industrial innovation, and global recognition through publications, patents, and awards.

Profile

Google scholar

Education

Mr. Mehrdad Esmaeilipour educational path demonstrates consistent dedication to the field of electronics. He earned a Diploma in Electronics from Azadegan Technical High School, laying the groundwork for his engineering career. Building upon this, he pursued an Associate Degree in Electronics at Islamic Azad University, which he completed. His academic journey culminated with a Bachelor’s Degree in Electronics Engineering Technology from Islamic Azad University in. This progressive academic training equipped him with expertise in circuit design, control systems, robotics, and electronic communication, forming the intellectual foundation for his professional achievements in advanced engineering systems.

Experience

Mr. Mehrdad Esmaeilipour professional experience is marked by leadership roles and high-impact engineering projects. he has worked as a Senior Electronics Engineer at Arya Plasma Gostar Pars Company, where he leads a production unit specializing in advanced circuit and board design for environmental applications. His work includes the development of intelligent air purification systems, wastewater treatment technologies, and microbial seawater purification devices, with several projects patented or pending intellectual property rights. Parallel to this, he has served as the CEO of Parsa Pardazesh Booshehr Sanat Company, where he established a thriving business in electronics and IT, mentoring students and creating employment opportunities. He has also contributed voluntarily to the Robotics Team of the Electrical Department at Islamic Azad University, where he has guided students in the development of robotic prototypes and advanced control systems. These roles demonstrate his ability to bridge industry, academia, and entrepreneurship.

Research Interest

His research interests focus on green electronics, cold plasma applications, robotics, intelligent control systems, and artificial intelligence in electronics engineering. He has been particularly engaged in developing sustainable solutions for wastewater treatment, renewable energy systems, and environmental monitoring devices. Another significant dimension of his research is the integration of AI technologies in control and data engineering, which he has explored through publications and conference presentations. His work on robotic systems, fuzzy logic controllers, and intelligent wearable technologies demonstrates a strong inclination toward blending theoretical design with real-world applications, always with the vision of reducing environmental impact and improving human well-being.

Awards

Mr. Mehrdad Esmaeilipour work has been recognized with multiple international awards and honors. Among the most notable are the Outstanding Contribution Award in Technological Devices, the Global Leaders Award – Enterprise Edition, and the International Material Scientist Award – Electronics Advancements Award. He has also received the Best Innovator Award at the International Research Excellence & Best Paper Awards and the Best Wearable Sensing Technology Award at Sensor Awards. His recognition extends globally with the Global Recognition Award™ and the Excellence in Environmental Sustainability and Impact Award. These accolades reflect his influence in electronics research and his contributions to sustainability-driven innovations.

Publications Top Notes

Mr. Mehrdad Esmaeilipour has contributed books, journal articles, and conference papers that highlight his expertise. His notable journal publications include:

Title: Advancements in Cold Plasma Technology for Electronic and Surface Sterilization Applications (Opast Journal.
Year: 2025
Citations: for its relevance in sterilization systems.

Title: Design, Construction and Performance Comparison of Fuzzy Logic Controller and PID Controller for Two-Wheel Balance Robot (Global Journal of Engineering Sciences).
Year: 2025
Citations: in robotics optimization studies.

Title: The Utilization of Artificial Intelligence Technologies in the Domain of Electronic Data Engineering (International Journal of Advanced Research).
Year: 2025
Citations: AI-based electronic engineering frameworks.

Title: Single Miller Compensation with Split Output and Current Amplifier Use in Three Stage Amplifiers to Drive Ultra Large Capacitive Loads (Civilica Proceedings).
Year: 2015
Citations: in amplifier design literature.

Title: Advanced Design, Simulation, Monitoring, Control, and Maintenance Strategies for Photovoltaic Solar Power Systems (Book, Simorgh Aseman Azargan Publishing)
Year: 2025
Citations: Renewable energy management systems.

Title: Electrical Safety Strategy (ESS Book) (Book, Simorgh Aseman Azargan Publishing).
Year: 2024–2025
Citations: Electrical safety standards.

Title: Electronic Electrical Control Communication Technical Language (EECC Book) (Book, 2023–2025, Simorgh Aseman Azargan Publishing).
Year: 2023–2025
Citations: Electronic communication methodologies.

Conclusion

Mr. Mehrdad Esmaeilipour embodies the role of an engineer who bridges innovation, sustainability, and societal responsibility. His academic background in electronics, coupled with his professional leadership in plasma-based systems and IT enterprises, has positioned him at the forefront of environmental and technological innovation. His research in robotics, artificial intelligence, and renewable energy illustrates his forward-looking vision, while his patents and awards underline his tangible impact. With his broad portfolio of publications, international conference presentations, and global recognition, Esmaeilipour stands out as a researcher and entrepreneur whose work not only advances engineering but also contributes to the urgent global need for sustainable solutions.

Xiao-Lian Zhang | Immunotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Xiao-Lian Zhang | Immunotechnology | Best Researcher Award

Immunology at Wuhan University TaiKang Medical School | Best Researcher Award

Prof. Xiao-Lian Zhang is an eminent immunologist and distinguished professor at Wuhan University, recognized globally for her pioneering work on infection, immunity, and glycobiology. She currently serves as the Hongyi and Luojia Distinguished Professor, Chairman of the Department of Immunology, and Professor at the State Key Laboratory of Virology, where she leads major research initiatives on host–pathogen interactions, vaccines, and immune evasion strategies. Her work has significantly shaped the understanding of intracellular pathogens, including Mycobacterium tuberculosis and hepatitis viruses, and her research outputs place her among the most influential scientists in infection and immunity.

Profile

Orcid

Education

Prof. Xiao-Lian Zhang earned her PhD in Biochemistry from the Hong Kong University of Science and Technology between, where she developed expertise in molecular immunology. She then pursued postdoctoral research training at the University of Maryland, College Park, USA, from, where she specialized in infection and immunity with a focus on molecular mechanisms of host–pathogen interactions. These academic experiences established the foundation for her future leadership in immunological research.

Experience

Throughout her career,Prof. Xiao-Lian Zhang has assumed prominent leadership positions that reflect her academic distinction. She is currently the director of the Hubei Provincial Key Laboratory of Allergic and Immune-related Diseases and has overseen multiple national-level research programs, including China’s Major Infectious Disease Programs under the Eleventh, Twelfth, and Thirteenth Five-Year Plans, as well as the Program. She has also been entrusted with key research projects funded by the National Natural Science Foundation of China, further reinforcing her position as a leader in the field. With publications and more patents (granted), her experience demonstrates an exceptional balance of academic, research, and translational innovation.

Research Interest

Her core research interests span infection and immunity of intracellular pathogens such as Mycobacterium tuberculosis, hepatitis B and C viruses, and typhoid. She has a particular focus on glyco-immunity, lectins such as ficolin-2/A, vaccine design, immune evasion mechanisms, and the development of diagnostic and therapeutic technologies. Her group has advanced the understanding of glycobiology in immune recognition, while also uncovering new pathways by which pathogens exploit glycan modifications to evade immune responses. These interests bridge fundamental molecular biology with clinical application, reflecting her dedication to translational immunology.

Award

Prof. Xiao-Lian Zhang has received numerous prestigious awards in recognition of her scientific excellence. She is a recipient of the National Outstanding Young Scientist Fund and has been honored as a national-level talent under the New Century Million Talent Project. She has also been named both “Hongyi Scholar” and “Luojia Scholar,” distinguished honors at Wuhan University, underscoring her contributions to science and academia. Additionally, her work has been repeatedly ranked among the top 2% of global research outputs by Faculty, further validating her international impact.

Publication Top Notes

Prof. Zhang’s contributions are reflected in her publications across top-tier journals such as Science Advances, Nature Communications, Journal of Immunology, and Nucleic Acids Research. Selected works include:

Title: Ficolin-A Protects Against Allergic Asthma via Suppressing ILC2-Driven Type 2 Inflammation.
Year: 2025
Citations: in studies on innate lymphoid cell regulation.

Title: EGFR Core Fucosylation Induced by Hepatitis C Virus Promotes TRIM40-Mediated RIG-I Ubiquitination and Suppresses Interferon-I Antiviral Defenses.
Year: 2024
Citations: in antiviral immunity research.

Title: Rapid Degradation of DHX36 Revealing its Transcriptional Role by Interacting with G-quadruplex.
Year: 2024
Citations: by molecular biology studies on G-quadruplex regulation.

Title: Lnc-EST12 Suppresses Anti-mycobacterial Innate Immunity Through Its Interaction with FUBP3.
Year: 2022
Citations: by tuberculosis immunity research.

Ttile: Mycobacterial EST12 Activates a RACK1-NLRP3-Gasdermin D Pyroptosis-IL-1β Immune Pathway.
Year: 2020
Citations: in inflammasome and pyroptosis studies.

Title: Binding of Cellular Nucleolin with the Viral Core RNA G-Quadruplex Structure Suppresses HCV Replication.
Year: 2019
Citations: in viral replication mechanism research.

Title: Foundational works in immune evasion strategies of intracellular pathogens – Journal of Immunology – Frequently cited in reviews on host–pathogen interactions.

Conclusion

In conclusion, Prof. Xiao-Lian Zhang stands as a global leader in immunological sciences, known for her pioneering discoveries in infection, glycobiology, and immunity. Her ability to integrate basic science with translational applications has led to significant advancements in vaccine design, diagnostic innovation, and therapeutic strategies against infectious diseases. With an outstanding publication record, prestigious awards, and leadership in national and international research initiatives, she continues to shape the future of infection and immunity research, serving as both a role model and trailblazer for the next generation of scientists.

Giuseppe D’Orazio | Nanobiotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Giuseppe D’Orazio | Nanobiotechnology | Best Researcher Award

University Researcher at University of Milan | Italy

Dr. Giuseppe D’Orazio is an accomplished academic researcher currently serving at the University of Milan, where he focuses on Organic and Carbohydrate Chemistry with applications in drug discovery, materials science, and biomedical research. His professional journey reflects a strong interdisciplinary approach, bridging chemistry and biology to address pressing challenges in pharmaceuticals, crop protection, and biomaterials. With more than fifteen years of post-graduate experience, he has contributed to both academia and industry, building an impressive portfolio of publications, patents, and collaborative projects across Italy and Europe. His research stands out for its innovative exploration of glycoderivatives, carbohydrate-based materials, and nanotechnology-inspired biomedical tools.

Profile

Orcid | Scopus | Google Scholar

Education

Dr. Giuseppe D’Orazio educational path reflects his deep dedication to biotechnology and chemistry. He earned his Bachelor’s degree in Biotechnology from the University of Milano-Bicocca, graduating with top honors for his thesis on the synthesis of iminosugar analogues as glycosidase inhibitors. He then pursued a Master’s degree in Industrial Biotechnology, specializing in Organic Chemistry, with research on sodium-glucose co-transporter (SGLT1) modulators that demonstrated strong anti-inflammatory properties. His academic development culminated in a PhD in Organic and Bioorganic Chemistry from the same university, with a dissertation titled “Glycoderivatives: drug candidates and molecular tools.” As part of his training, he gained international experience as a visiting PhD student at CICbiomaGUNE in Spain, where he worked on functionalizing gold nanoparticles with bioactive compounds.

Experience

Dr. Giuseppe D’Orazio professional career encompasses both academic and industrial research environments. He began with research fellowships in analytical chemistry, focusing on food traceability and nutraceutical analysis. he served as a postdoctoral researcher at the University of Milano-Bicocca, where he investigated bioactive molecules of pharmacological interest, trained students, and contributed to teaching activities. He also gained consultancy experience with Eisai s.r.l., where he carried out chemical analysis of drug stability. he transitioned into industry as a Chemistry Researcher at Isagro S.p.A., leading projects in agrochemical discovery and developing novel crop protection agents, while also filing multiple patents. His academic career resumed at the Polytechnic University of Bari where he focused on functional and sustainable materials before joining the University of Milan as a researcher in Organic Chemistry. In his current role, he develops carbohydrate-based molecules, glycoconjugates, and nanostructures with applications in vaccines, immunology, and cancer therapy.

Research Interests

His research interests span a wide range of disciplines within chemistry and biotechnology. Central to his work is Carbohydrate Chemistry and Glycoconjugates, with applications in biomedical sciences, including the design of vaccine adjuvants and cancer therapeutics. He has a strong interest in synthetic organic chemistry, particularly in the development of new ligands, glycoderivatives, and bioactive molecules. His work also explores gold nanoparticle functionalization, aiming to create nanoscale tools for drug delivery and immune modulation. Additionally, he has contributed to crop protection chemistry, discovering new molecules for plant health and sustainability, and to analytical chemistry, developing techniques for structural characterization and evaluating the biological efficacy of compounds.

Awards

Dr. Giuseppe D’Orazio has received several recognitions for his scientific contributions. Among them, he won the Best Poster Award at the XVIII Conference-School on Carbohydrate Chemistry, for presenting innovative vaccine adjuvant research inspired by the lipid A structure of Bacteroides fragilis. He has also been entrusted with significant editorial roles, serving as a guest editor for special issues in journals such as Applied Sciences and Biomedicines. His expertise is recognized through appointments to advisory panels, journal reviewer duties, and participation in international collaborative research projects funded by European and Italian institutions.

Publications Top Notes

Dr. Giuseppe D’Orazio has authored more than 30 peer-reviewed papers and one book chapter, with a citation record exceeding 700 citations on Google Scholar. Below are seven representative publications:

Title: Gold Nanoparticles functionalized with ABO Blood Sugar Antigen as Nanotools for Biomedical Applications. Carbohydrate Research.
Year: 2025
Citations- 3

Title: Functional Polarization of Liver Macrophages by Glyco Gold Nanoparticles. Advanced Science.
Year: 2024
Citations: 15

Title: Anti-Inflammatory Effects of SGLT1 Synthetic Ligand in In Vitro and In Vivo Models of Lung Diseases. Immuno.
Year: 2024
Citations: 10

Title: Synthesis of a Small Library of Glycoderivative Ligands of SGLT1. Molecules.
Year: 2024
Citations: 08

Title: Domino Reactions on Carbohydrates: State of the Art. European Journal of Organic Chemistry.
Year: 2024
Citations: 12

Ttile: Semisynthetic Glycoconjugates as Potential Vaccine Candidates Against Haemophilus influenzae Type a. Chemistry – A European Journal.
Year: 2024
Citations: 09

Title: Dual-Targeting Gold Nanoparticles: Simultaneous Decoration with Ligands for Co-Transporters SGLT-1 and B0AT1. Applied Sciences.
Year: 2024
Citations- 07

Conclusion

Dr. Giuseppe D’Orazio career demonstrates a consistent pursuit of innovation at the interface of chemistry and biology. His work in carbohydrate chemistry, nanomaterials, and bioorganic synthesis has produced both fundamental insights and practical applications in medicine and agriculture. With a strong background in industrial research and academic scholarship, he exemplifies the modern interdisciplinary scientist who bridges discovery with application. His contributions, spanning publications, patents, and international collaborations, underline his role as a forward-looking researcher whose efforts are shaping advancements in biotechnology, organic chemistry, and drug discovery.

Rakesh Singh Negi | Radiochemistry | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Rakesh Singh Negi | Radiochemistry | Best Researcher Award

Senior Researcher at Department of Chemistry P.N.G Govt PG College Ramnagar | India

Dr. Rakesh Singh Negi is a nuclear chemist and environmental researcher whose work bridges the domains of radiation science, groundwater chemistry, and environmental risk assessment. Currently serving as a researcher at the Department of Chemistry, P.N.G. Government PG College Ramnagar, Nainital, he has cultivated expertise in radiation detection, nuclear instrumentation, and the monitoring of naturally occurring radioactive materials in water systems. His academic path and research contributions highlight a deep commitment to understanding environmental radioactivity, heavy metal contamination, and radiation protection strategies. He combines technical proficiency with field-based investigations to address pressing challenges in water safety and public health, particularly in the Himalayan region.

Profile

Orcid

Education

Dr. Rakesh Singh Negi academic journey began at Kumaun University, Nainital, where he earned his Bachelor of Science degree in Chemistry, Zoology, and Botany , followed by a Master of Science in Organic Chemistry in. Building upon this foundation, he pursued doctoral research in chemistry, completing his Ph.D. under the guidance of Prof. Jagmohan Singh Negi. His doctoral thesis, titled “A Comprehensive Study on Water Quality Parameters and Natural Radioactivity in Drinking Water of Urban Part of Kumaun Himalaya, India,” examined the interplay between natural radioactivity and water quality in Himalayan urban regions. His academic progression demonstrates a consistent focus on chemistry and environmental sciences, enabling him to specialize in nuclear chemistry and radiation-based risk assessments.

Experience

Dr. Rakesh Singh Negi has combined academic rigor with applied scientific investigation. At P.N.G. Government PG College Ramnagar, Nainital, he has taught both undergraduate and postgraduate chemistry courses, integrating his research into teaching and inspiring students to pursue analytical and environmental sciences. His experience extends to laboratory training, student mentoring, and guiding independent research projects. Beyond teaching, he has actively participated in national and international conferences, presenting his findings on radon exposure, uranium contamination, and heavy metal toxicity. His practical knowledge of advanced radiation detection systems, water analysis tools, and statistical risk assessment methods has positioned him as both a scientist and mentor. Additionally, he has attended faculty development programs such as the workshop on Principles of Radiation Detection and Measurement and Experimental Techniques organized by Ramjas College, University of Delhi, which further enriched his methodological expertise.

Research Interest

Dr. Rakesh Singh Negi primary research interests revolve around environmental radioactivity, nuclear instrumentation, and water quality assessment. His work focuses on quantifying radiation exposure from radon and uranium in groundwater, assessing dose risks, and comparing contamination levels with international safety standards. He is particularly concerned with the occurrence of potentially toxic elements in potable water sources, their health implications, and strategies for sustainable water management. His interests also encompass heavy metal analysis, ionizing radiation, and radiation protection. By combining nuclear chemistry with environmental monitoring, he addresses interdisciplinary challenges that have implications for both public health and environmental sustainability, particularly in fragile ecosystems like the Kumaun Himalaya.

Award

While still in the early stages of his career, Dr. Rakesh Singh Negi academic excellence and scientific contributions have been acknowledged through active participation in prestigious conferences, workshops, and collaborative research initiatives. His research outputs in peer-reviewed journals and his engagement in national and international platforms reflect recognition within the scientific community. His contributions toward environmental safety and nuclear chemistry position him as a promising researcher with potential for broader recognition in the future.

Publications Top Notes

Title: Distribution and risk estimation of potentially toxic elements in potable groundwater of Kumaun Himalaya, India.
Year: 2024

Title: Study of radiation exposure to radon in groundwater using scintillation-based RnDuo technique: A statistical analysis for risk assessment.
Year: 2025

Title: LED fluorometric analysis of uranium in potable groundwater and associated health concerns.
Year: 2024

Title: Groundwater Quality Assessment in the Foothills of the Kumaun Himalaya, India.
Year: 2025

Title: Exposure to Potentially Toxic Elements in Groundwater of Kumaun Foothills: Statistical Analysis of Contamination and Human Health Risk.
Year: 2025

Title: Measurement of radon concentration in soil samples along and across main central thrust of Garhwal Himalaya, India
Year: 2022

Title: Radiological and chemical risk assessment of Uranium in potable groundwater sources in Kumaun Himalaya, India.
Year: 2023

Conclusion

In conclusion, Dr. Rakesh Singh Negi exemplifies a new generation of researchers who merge nuclear chemistry with environmental sustainability to address water safety challenges in ecologically sensitive regions. His work highlights the importance of radiation detection and heavy metal monitoring in safeguarding human health, particularly in the Himalayan region where groundwater is a critical resource. With a strong academic foundation, active teaching experience, and significant contributions through research and publications, Dr. Rakesh Singh Negi is building a career that integrates science, education, and environmental stewardship. His research outcomes provide not only valuable scientific insights but also practical frameworks for policymakers and environmental health experts working to ensure safe water resources. His trajectory reflects a blend of academic excellence, innovative research, and a commitment to community well-being, marking him as a promising contributor to the fields of nuclear chemistry and environmental risk assessment.

WEI CAO | Clinical Biotechnology | Young Researcher Award

Published on by Biotechnology Scientist

Prof. WEI CAO | Clinical Biotechnology | Young Researcher Award

Professor | Shanghai Jiao Tong University School of Medicine Affiliated Ninth People’s Hospital | China

Wei Cao, MD, PhD, is a distinguished Professor at the Department of Oral and Maxillofacial–Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. Renowned for his expertise in head and neck cancers, especially oral squamous cell carcinoma, he has contributed significantly to understanding tumor biology, recurrence mechanisms, and therapeutic resistance. With an H-index of and citations, he has authored impactful research shaping the field of oral oncology. His editorial appointments in high-impact journals and active membership in global medical associations further reflect his academic stature and leadership in oncology research.

Profile

Scopus | Orcid

Education

Wei Cao earned his Diploma in Oral Medicine from Zhengzhou University School of Medicine. He then pursued his MD and PhD at Shanghai Jiao Tong University School of Medicine, completing his doctoral training in Head and Neck Surgical Oncology in. To enhance his research scope and gain international exposure, he undertook postgraduate training in the Department of Oncology and Diagnostic Sciences at the University of Maryland Dental School in the USA. His educational journey has provided him with a strong foundation in both clinical practice and biomedical research.

Experience

Over his career, Wei Cao has progressed through academic and clinical ranks, starting as a Fellow in the Department of Oral and Maxillofacial–Head and Neck Oncology and later serving as a Surgeon  in the same department. He was appointed Associate Professor in and Consultant before becoming Professor. Alongside his hospital responsibilities, he plays key editorial roles in journals such as Frontiers in Oncology and Technology in Cancer Research & Treatment, and serves on multiple editorial boards including BMC Cancer and Cancer Biology & Medicine. His professional affiliations include the American Association for Cancer Research and the Royal Society of Medicine.

Research Interest

Cao’s research focuses on the molecular mechanisms underlying the initiation, progression, and recurrence of oral and head and neck cancers. He investigates tumor microenvironment interactions, immunotherapy responses, and the role of non-coding RNAs in cancer biology. His work also explores novel biomarkers for prognosis, mechanisms of therapy resistance, and the development of personalized treatment strategies. Integrating single-cell transcriptomics, molecular pathology, and clinical data, his research aims to improve survival outcomes and quality of life for cancer patients.

Award

Wei Cao’s research excellence has been recognized with numerous honors, including the CYTO Student Travel Award, Excellent Doctoral Dissertation in Shanghai, and multiple national and institutional science and technology awards such as the 2nd Prize from the Chinese Medical Association and the National Ministry of Education.he was named among the “Outstanding Young Oncologists” by the Chinese Society of Clinical Oncology and received the Outstanding Young Scholar and Kowloon Outstanding Young Talent Awards from Shanghai Jiao Tong University School of Medicine.

Publication Top Notes

Cao has an extensive publication record in high-impact journals. Seven representative works include:

Title:  Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma,” Int J Oral Sci.
Year: 2024
Citations: 2

Title:  LINC02454-CCT complex interaction is essential for telomerase activity and cell proliferation in head and neck squamous cell carcinoma, Cancer Lett.
Year: 2024
Citations: 3

Title:  CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma,” Int J Immunopathol Pharmacol.
Year: 2024
Citations: 1

Title:  Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation, Adv Sci (Weinh).
Year: 2023
Citations: 6

Title:  EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma,” Biomolecules.
Year: 2023
Citations: 5

Title:  Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments, Cell Metab.
Year: 2022
Citations: 44

Title: Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance, Oral Dis.
Year: 2023
Citations: 8

Conclusion

Professor Wei Cao has established himself as a leader in oral and head and neck oncology through a career that bridges clinical excellence and groundbreaking research. His contributions to elucidating molecular mechanisms, identifying prognostic biomarkers, and advancing therapeutic strategies have significantly impacted patient care and cancer biology. With a robust portfolio of high-impact publications, prestigious awards, and leadership roles in international journals, he continues to shape the future of cancer research. His work reflects a commitment to innovation, interdisciplinary collaboration, and improving clinical outcomes for patients facing complex oncological challenges.